Ardena, a leading Contract Development and Manufacturing Organization (CDMO) dedicated to advancing molecules to the clinics, is pleased to announce a significant addition to its business development team. We welcome Tara Hope, who has recently joined Ardena as the Business Development Director for Drug Product and CMC Regulatory Services, with a primary focus on the UK and the Nordics.
Tara brings a wealth of knowledge and experience to her new role at Ardena. With a Bachelor of Science degree in Applied Biology, she boasts nearly two decades of expertise in the pharmaceutical industry. Tara has held pivotal positions, including Head of Commercial and Business Development Director at SGS Quay Pharma, as well as serving as a Technical Sales Executive at Byotrol.
In her role as Business Development Director, Tara will focus on driving business growth in the areas of Drug Product development and manufacturing services, as well as our expert CMC Regulatory capabilities. Her efforts will be instrumental in further strengthening Ardena’s presence in the UK and the Nordics, aligning perfectly with Ardena’s mission to streamline drug development processes and deliver top-tier services to clients worldwide.